Format

Send to

Choose Destination
Cuad Bioet. 2017 Jan-Apr;28(92):71-81.

[Therapeutic Aggressiveness and Liquid Oncology].

[Article in Spanish]

Author information

1
Servicio de Oncología Médica. Hospital Clínico Universitario de Santiago. Trv Choupana s/n. Santiago de Compostela A Coruña. Tfno. 676903416 correo: paco.baron@ telefonica.net.
2
Medicina Legal y Forense de la Universidad de Santiago de Compostela.
3
Comisión de Ética y Deontología del Colegio de Médicos de A Coruña.

Abstract

Aggressiveness criteria proposed in the scientific literature a decade ago provide a quality judgment and are a reference in the care of patients with advanced cancer, but their use is not generalized in the evaluation of Oncology Services. In this paper we analyze the therapeutic aggressiveness, according to standard criteria, in 1.001 patients with advanced cancer who died in our Institution between 2010 and 2013. The results seem to show that aggressiveness at the end of life is present more frequently than experts recommend. About 25% of patients fulfill at least one criterion of aggressiveness. This result could be explained by a liquid Oncology which does not prioritize the patient as a moral subject in the clinical appointment. Medical care is oriented to necessities and must be articulated in a model focused on dignity and communication. Its implementation through Advanced Care Planning, consideration of patient's values and preferences, and Limitation of therapeutic effort are ways to reduce aggressiveness and improve clinical practice at the end of life. We need to encourage synergic and proactive attitudes, adding the best of cancer research with the best clinical care for the benefit of human being, moral subject and main goal of Medicine.

PMID:
28342435
[Indexed for MEDLINE]
Free full text

Supplemental Content

Full text links

Icon for Asociacion Espanola de Bioetica y Etica Medica
Loading ...
Support Center